X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5615) 5615
Newsletter (59) 59
Magazine Article (17) 17
Book Chapter (11) 11
Newspaper Article (4) 4
Dissertation (3) 3
Journal / eJournal (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4749) 4749
male (2387) 2387
female (2109) 2109
index medicus (2058) 2058
antifungal agents - therapeutic use (2031) 2031
amphotericin b - therapeutic use (2003) 2003
adult (1693) 1693
middle aged (1624) 1624
amphotericin b (1424) 1424
amphotericin-b (1358) 1358
amphotericin b - adverse effects (1307) 1307
infectious diseases (1170) 1170
amphotericin b - administration & dosage (1133) 1133
antifungal agents - adverse effects (1030) 1030
pharmacology & pharmacy (1027) 1027
antifungal agents - administration & dosage (959) 959
aged (943) 943
mycoses - drug therapy (873) 873
microbiology (867) 867
treatment outcome (858) 858
animals (783) 783
adolescent (779) 779
liposomal amphotericin-b (753) 753
voriconazole (696) 696
candidiasis - drug therapy (686) 686
fluconazole (680) 680
child (645) 645
immunology (633) 633
aspergillosis (599) 599
transplantation (580) 580
fungal-infections (556) 556
health aspects (551) 551
antifungal agents (548) 548
mycoses (547) 547
therapy (514) 514
aspergillosis - drug therapy (512) 512
risk factors (512) 512
infections (494) 494
immunocompromised host (487) 487
antiparasitic agents (474) 474
drug therapy, combination (464) 464
care and treatment (441) 441
retrospective studies (430) 430
drug therapy (426) 426
itraconazole (405) 405
antifungal agents - pharmacology (404) 404
fungal infections (403) 403
child, preschool (395) 395
hematology (391) 391
candidiasis (364) 364
fluconazole - therapeutic use (363) 363
oncology (363) 363
invasive fungal-infections (361) 361
diagnosis (355) 355
caspofungin (354) 354
infection (352) 352
medicine, general & internal (349) 349
triazoles - therapeutic use (341) 341
mortality (340) 340
mycology (338) 338
efficacy (337) 337
research (333) 333
pharmacokinetics (328) 328
liposomes (327) 327
safety (314) 314
antifungal agents - pharmacokinetics (313) 313
mycoses - prevention & control (313) 313
surgery (310) 310
infant (308) 308
invasive aspergillosis (305) 305
epidemiology (304) 304
double-blind (299) 299
risk-factors (298) 298
amphotericin b - pharmacology (294) 294
toxicity (291) 291
neutropenia (290) 290
neutropenic patients (287) 287
cancer (284) 284
pediatrics (272) 272
drug combinations (267) 267
young adult (265) 265
leishmaniasis, visceral - drug therapy (260) 260
medicine & public health (260) 260
analysis (259) 259
prospective studies (256) 256
echinocandins (254) 254
visceral leishmaniasis (249) 249
in-vitro (247) 247
dosage and administration (245) 245
prophylaxis (245) 245
microbial sensitivity tests (241) 241
mycoses - etiology (237) 237
antiprotozoal agents - therapeutic use (235) 235
mice (235) 235
lipopeptides (233) 233
aged, 80 and over (230) 230
drugs (226) 226
antifungal therapy (225) 225
candida (222) 222
dermatology (222) 222
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5336) 5336
Spanish (107) 107
French (89) 89
German (69) 69
Japanese (60) 60
Portuguese (16) 16
Dutch (15) 15
Chinese (13) 13
Russian (9) 9
Italian (8) 8
Polish (6) 6
Czech (4) 4
Turkish (4) 4
Danish (3) 3
Hebrew (3) 3
Finnish (2) 2
Hungarian (2) 2
Norwegian (2) 2
Swedish (2) 2
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA ophthalmology, ISSN 2168-6165, 07/2014, Volume 132, Issue 7, pp. 832 - 837
.... Most postkeratoplasty endophthalmitis and keratitis cases are now of a fungal origin. OBJECTIVE: To assess the efficacy and safety of voriconazole and amphotericin B in reducing Candida species contamination of Optisol-GS under normal storage conditions... 
VORICONAZOLE | PRESERVATION MEDIUM | DONOR CORNEAS | RIM CULTURES | PENETRATING KERATOPLASTY | ENDOTHELIAL-CELLS | SUSCEPTIBILITY | OPHTHALMOLOGY | FUNGAL ENDOPHTHALMITIS | EYE-BANKING | TRANSPLANTATION | Dextrans - adverse effects | Triazoles - adverse effects | Antifungal Agents - adverse effects | Cornea | Cell Count | Humans | Organ Preservation | Culture Media, Serum-Free - adverse effects | Drug Contamination - prevention & control | Colony Count, Microbial | Endothelium, Corneal - pathology | Candidiasis - microbiology | Microbial Sensitivity Tests | Candidiasis - prevention & control | Candida albicans - drug effects | Chondroitin Sulfates - adverse effects | Complex Mixtures - pharmacology | Endothelium, Corneal - microbiology | Dextrans - pharmacology | Gentamicins - pharmacology | Voriconazole | Culture Media, Serum-Free - pharmacology | Antifungal Agents - pharmacology | Organ Preservation Solutions - adverse effects | Gentamicins - adverse effects | Amphotericin B - pharmacology | Treatment Outcome | Chondroitin Sulfates - pharmacology | Organ Preservation Solutions - pharmacology | Endothelium, Corneal - drug effects | Pyrimidines - pharmacology | Complex Mixtures - adverse effects | Amphotericin B - adverse effects | Triazoles - pharmacology | Pyrimidines - adverse effects | Tissue Donors | Drug Combinations | Candida glabrata - drug effects | Care and treatment | Keratitis | Amphotericin B | Endophthalmitis | Dosage and administration | Diagnosis | Research | Risk factors | Fungal antigens
Journal Article
Cochrane library, ISSN 1469-493X, 2014, Volume 2020, Issue 6, p. CD004707
.... Objectives To compare the benefits and harms of voriconazole with those of amphotericin B and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia... 
'ORPHAN' TOPICS CURRENTLY BEING ADDRESSED | Infections in neutropenic cancer patients | Fluconazole | Mycoses | Neoplasms | Randomized Controlled Trials as Topic | Opportunistic Infections | Pyrimidines | Infections in neutropenic patients | Amphotericin B | Triazoles | Aspergillosis | Voriconazole | Antifungal Agents | Liposomes | Medicine General & Introductory Medical Sciences | General cancer treatments | Neutropenia | Cancer | Amphotericin B [adverse effects; therapeutic use] | Humans | Aspergillosis [drug therapy] | Opportunistic Infections [drug therapy] | PREVENTION | EMPIRICAL ANTIFUNGAL THERAPY | Triazoles [adverse effects; therapeutic use] | Mycoses [drug therapy] | FUNGAL-INFECTIONS | TRIAL | Neutropenia [drug therapy; microbiology] | MEDICINE, GENERAL & INTERNAL | Antifungal Agents [adverse effects; therapeutic use] | Pyrimidines [adverse effects; therapeutic use] | Fluconazole [adverse effects; therapeutic use] | DOUBLE-BLIND | Neoplasms [complications] | Triazoles - adverse effects | Antifungal Agents - adverse effects | Fluconazole - adverse effects | Opportunistic Infections - mortality | Fluconazole - therapeutic use | Neutropenia - drug therapy | Antifungal Agents - therapeutic use | Opportunistic Infections - microbiology | Amphotericin B - adverse effects | Neoplasms - complications | Pyrimidines - therapeutic use | Neutropenia - microbiology | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Neutropenia - mortality | Pyrimidines - adverse effects | Mycoses - mortality | Amphotericin B - therapeutic use | Aspergillosis - drug therapy | Triazoles - therapeutic use
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2017, Volume 376, Issue 24, pp. 2329 - 2340
Journal Article
Critical Care Medicine, ISSN 0090-3493, 06/2010, Volume 38 Suppl, Identification and Prevention of Common Adverse Drug Events in the Intensive Care Unit, Issue 6, pp. S169 - S174
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 07/2018, Volume 2018, Issue 7, p. CD009012
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10020, pp. 760 - 769
Journal Article
The Lancet, ISSN 0140-6736, 2005, Volume 366, Issue 9495, pp. 1435 - 1442
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2002, Volume 347, Issue 6, pp. 408 - 415
Journal Article